These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1459205)

  • 1. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.
    Ono M; Nakayama Y; Princler G; Gopas J; Kung HF; Kuwano M
    Exp Cell Res; 1992 Dec; 203(2):456-65. PubMed ID: 1459205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of mouse BALB/3T3 cells by polyoma middle T antigen requires epidermal growth factor receptor expression.
    Ono M; Kuwano M; Kung HF
    Cell Growth Differ; 1991 Jul; 2(7):317-22. PubMed ID: 1782150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubule reorganization and lysosome redistribution by a viral v-src oncogene, in mouse Balb/3T3 cells expressing human EGF receptor.
    Nakayama Y; Hisano T; Okimoto T; Tanaka Y; Ishikawa T; Himeno M; Ono M; Kuwano M
    Cell Struct Funct; 1994 Dec; 19(6):397-409. PubMed ID: 7720100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation by viral and cellular oncogenes of a mouse BALB/3T3 cell mutant resistant to transformation by chemical carcinogens.
    Ono M; Yakushinji M; Segawa K; Kuwano M
    Mol Cell Biol; 1988 Oct; 8(10):4190-6. PubMed ID: 3054511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of cytokeratin 14 gene expression by the polyoma virus middle T antigen is dependent on c-Src association but independent of full transformation in rat liver nonparenchymal epithelial cells.
    Royal I; Raptis L; Druker BJ; Marceau N
    Cell Growth Differ; 1996 Jun; 7(6):737-43. PubMed ID: 8780887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
    Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
    Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
    Riedel H
    J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts.
    Reihsaus E; Kraiss S; Barnekow A; Montenarh M
    Exp Cell Res; 1992 Mar; 199(1):10-8. PubMed ID: 1735451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of doxorubicin on pp60c-src kinase activity in polyoma virus MT antigen transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1994; 14(6B):2529-35. PubMed ID: 7532928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
    Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
    Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells.
    Pickett CA; Gutierrez-Hartmann A
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8612-6. PubMed ID: 8078931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor.
    Gotoh N; Tojo A; Hino M; Yazaki Y; Shibuya M
    Biochem Biophys Res Commun; 1992 Jul; 186(2):768-74. PubMed ID: 1323290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal regulation of a polyoma virus middle-size T-antigen gene linked to growth hormone control sequences.
    Heiser WC; Eckhart W
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2147-60. PubMed ID: 2995552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
    Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
    J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function.
    Talmage DA; Riney C; Benjamin TL
    Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.
    Baulida J; Kraus MH; Alimandi M; Di Fiore PP; Carpenter G
    J Biol Chem; 1996 Mar; 271(9):5251-7. PubMed ID: 8617810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of v-src transforming activity by simian virus 40 small t antigen.
    Wang WB; Kao TM; Yang C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Nov; 29(4):173-84. PubMed ID: 10592800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
    Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
    Cancer Res; 1988 Nov; 48(21):6076-80. PubMed ID: 3139288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.